PubMed Health⌕ Search

Biomedical subjects

P Moke

Publications and source records attributed to P Moke.

2 recordsLinked to original sources

Parametric and non-parametric tests for the overall comparison of several treatments to a control when treatment is expected to increase variability.

We consider the problem of making an overall comparison of several treatments to a control where experimental units are randomly assigned to either the 'control' group which receives no treatment or to one of k-1 'treatment' groups. We assume that the effect of the treatments is, if anything, a location shift possibly accompanied by an increase in scale relative to that of the control group. The ANOVA F test loses considerable power in such circumstances. A modification of the ANOVA F test has been proposed which uses the variance estimate from the controls in place of the usual pooled variance estimate. However, this modification has shortcomings when k exceeds two and the variances of the treatment groups are not inflated. We develop a combination procedure to avoid the pitfalls of the modified and usual F tests. We then propose parametric and non-parametric implementations of a likelihood ratio test that more efficiently incorporates the assumptions of this problem, yielding a test with a high power profile over a large range of normal alternatives. We use simulations to compare the power of the competing tests against several alternatives for normal and non-normal data.

Analysis of Variance↗

Uveitis associated with topical beta-blockers.

OBJECTIVE: To assess the incidence of uveitis associated with topical beta-blockers. DESIGN: Retrospective cohort study. SETTING: A computerized database of a health maintenance organization was used to identify patients who were prescribed metipranolol or other beta-blockers. PATIENTS: Two groups: 1928 patients using 0.3% metipranolol and 3903 patients using other beta-blockers. MAIN OUTCOME MEASURE: Cases of uveitis were identified by noting a prescription of a topical corticosteroid and then conducting a chart review. RESULTS: No cases of uveitis were identified among the 5831 patients. The upper limits of the 95% confidence intervals for the incidence of uveitis in cohorts of this size are 1.87 cases per 1000 person-years of exposure for metipranolol and 1.38 for other beta-blockers. CONCLUSION: Drug-induced uveitis from metipranolol or other beta-blocker administration is a rare event, even if a causal relationship exists.

Administration, Topical↗